AstraZeneca Canada Inc.
Records under this name other than patents AstraZeneca Canada Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to AstraZeneca Canada Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,530,467 | Benzoimidazole Compounds and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 9,814,725 | Imidazopyridine Compounds and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 9,937,185 | Imidazopyridine Compounds and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 9,598,409 | Imidazopyridine Compounds and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 6,087,489 | Antisense oligonucleotide modulation of human thymidylate synthase expression Formerly held Term ended Term ended Jun 2, 2018 · From the USPTO record | Term ended | Term ended Jun 2, 2018 | From the USPTO record |
| US 6,187,792 | Compounds with analgesic effect Term ended Term ended Mar 5, 2018 · From the USPTO record | Term ended | Term ended Mar 5, 2018 | From the USPTO record |
| US 6,153,626 | Compounds with analgesic effect Term ended Term ended Mar 3, 2018 · From the USPTO record | Term ended | Term ended Mar 3, 2018 | From the USPTO record |
| US 6,974,825 | Compounds with analgesic effect Lapsed on the fee record Ended Dec 13, 2017 · From the USPTO record | Lapsed on the fee record | Ended Dec 13, 2017 | From the USPTO record |
| US 7,375,207 | Galanin Receptor 2 Proteins and Nucleic Acids Formerly held Lapsed on the fee record Ended May 20, 2016 · Medium confidence | Lapsed on the fee record | Ended May 20, 2016 | Medium confidence |
| US 6,710,179 | Compounds with analgesic effect Lapsed on the fee record Ended Mar 23, 2016 · From the USPTO record | Lapsed on the fee record | Ended Mar 23, 2016 | From the USPTO record |